SARBEVAX Trademark

Trademark Overview


On Thursday, November 10, 2022, a trademark application was filed for SARBEVAX with the United States Patent and Trademark Office. The USPTO has given the SARBEVAX trademark a serial number of 79368313. The federal status of this trademark filing is REGISTERED as of Tuesday, August 27, 2024. This trademark is owned by POPVAX PRIVATE LIMITED. The SARBEVAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and medical preparations for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related d...
sarbevax

General Information


Serial Number79368313
Word MarkSARBEVAX
Filing DateThursday, November 10, 2022
Status700 - REGISTERED
Status DateTuesday, August 27, 2024
Registration Number7483965
Registration DateTuesday, August 27, 2024
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 11, 2024

Trademark Statements


Description of MarkSarbevax.
Goods and ServicesPharmaceutical and medical preparations for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; pharmaceuticals, medical and veterinary preparations for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; biological preparations for medical purposes, for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; biological preparations for veterinary purposes, for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; chemical preparations for medical purposes for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; chemical preparations for pharmaceutical purposes for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; diagnostic preparations for medical purposes for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; drugs for medical purposes for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; medicines for human purposes for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; vaccines for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose; medical, biological and pharmaceutical preparations for scientific, research, medical, or pharmaceutical use, namely, preparations for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, and reproductive disorders; medical, biological and pharmaceutical preparations containing nucleic acids or proteins for the prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, and reproductive disorders; a full line of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, biosimilars and therapeutic for prevention and treatment of infectious diseases, rare diseases, cancers, neurological disorders, cardiovascular disorders, lymphatic disorders, inflammatory disorders, immunoregulatory disorders, immunological disorders, metabolic disorders, reproductive disorders, autoimmune disorders, respiratory disorders, endocrine system related disorders, nephrological disorders, hepatic disorders, haematological disorders, pulmonary disorders, gene or protein regulatory disorders, epigenetic disorders, gastro-intestinal disorders, disorders of the ear, nose and throat, muscular disorders, skeletal disorders, musculo-skeletal disorders, genetic disorders, oral and dental disorders, psychological disorders, psychiatric disorders, neonatal and natal disorders, ageing, ageing associated disorders, skin disorders, ophthalmic disorders, protein deficiency disorders, vitamin deficiency disorders, obstetric and gynaecological disorders, sexual health related disorders, allergic disorders, obesity or obesity related conditions, injuries, wounds, wound-healing conditions, sleep disorders, fatigue disorders, venom or toxin related conditions, addiction and addiction related conditions, and drug overdose.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 28, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePOPVAX PRIVATE LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressIN

Party NamePOPVAX PRIVATE LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIN

Party NamePOPVAX PRIVATE LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIN

Trademark Events


Event DateEvent Description
Tuesday, May 2, 2023APPLICATION FILING RECEIPT MAILED
Thursday, April 27, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, April 28, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 24, 2023ASSIGNED TO EXAMINER
Monday, March 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 18, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 1, 2023NON-FINAL ACTION WRITTEN
Saturday, September 2, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 21, 2023REFUSAL PROCESSED BY MPU
Thursday, September 21, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 11, 2023REFUSAL PROCESSED BY IB
Monday, March 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 22, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 11, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 11, 2024PUBLISHED FOR OPPOSITION
Wednesday, June 12, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, July 1, 2024ASSIGNED TO PETITION STAFF
Tuesday, August 27, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 9, 2024POST PUBLICATION AMENDMENT – NOT ENTERED
Tuesday, August 27, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, November 4, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 4, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 4, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, November 4, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 27, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, February 14, 2025FINAL DISPOSITION NOTICE SENT TO IB
Saturday, March 8, 2025FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 13, 2025FINAL DISPOSITION PROCESSED